PEN Stock: Price, Earnings History and SEC Filings
Penumbra, Inc. (PEN) last traded at $318.95, down 0.94% on the latest session and up 0.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.88 against an analyst estimate of $1.15, a miss of 23.5%.
$318.95 -0.94%
1 month+0.19%
52-week high$362.41
52-week low$221.26
Volume497,163
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PEN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 30, 2026 | $0.88 | $1.15 | -23.48% |
| Mar 2026 | May 6, 2026 | $0.82 | $1.11 | -26.13% |
| Dec 2025 | Feb 25, 2026 | $1.18 | $1.12 | +5.36% |
PEN beat the analyst EPS estimate in 1 of its last 3 reported quarters. Source: Nasdaq.
Latest SEC filings for PEN
SEC filing data is not available right now. You can search for PEN on SEC EDGAR.
PEN news
- Penumbra (PEN) Stock Faces Q3 Earnings Valuation ScrutinyOct 31, 2026 · finance.yahoo.com
- Penumbra: Q3 Earnings SnapshotOct 29, 2026 · finance.yahoo.com
- Penumbra, Inc. Reports Third Quarter 2026 Financial ResultsOct 29, 2026 · finance.yahoo.com
- BSX Q3 Earnings Call Flags Growth Challenges Through 2027Oct 29, 2026 · finance.yahoo.com
- Boston Scientific Q3 Earnings Call HighlightsOct 29, 2026 · marketbeat.com
- Boston Scientific: 3 Key Takeaways for Long-Term InvestorsOct 29, 2026 · fool.com
- Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)Oct 20, 2026 · finance.yahoo.com
About Penumbra, Inc.
Penumbra, Inc. (PEN) is a US-listed public company on NYSE.